Hybrid Closed-Loop System Achieves Optimal Perioperative Glycemia in a Boy With Type 1 Diabetes: A Case Report

The goal in type 1 diabetes (T1D) therapy is to maintain optimal glycemic control under any circumstance. Diabetes technology is in continuous development to achieve this goal. The most advanced Food and Drug Administration- and European Medicines Agency-approved devices are hybrid closed-loop (HCL)...

Descripción completa

Detalles Bibliográficos
Autores principales: Dominguez-Riscart, Jesus, Buero-Fernandez, Nuria, Garcia-Zarzuela, Ana, Marmolejo-Franco, Fernando A., Perez-Guerrero, Ana C., Lechuga-Sancho, Alfonso M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pediatrics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116592/
https://www.ncbi.nlm.nih.gov/pubmed/33996680
http://dx.doi.org/10.3389/fped.2021.625390

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8116592/
https://www.ncbi.nlm.nih.gov/pubmed/33996680
http://dx.doi.org/10.3389/fped.2021.625390

Ejemplares similares